Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Bladder Cancer
100%
Somatic Variants
100%
Urine Exosomes
100%
Extrachromosomal DNA
75%
Diagnostic Tool
12%
Healthy Individuals
12%
KRAS mutation
12%
Whole Exome Sequencing
12%
Binding Region
12%
Peripheral Blood Mononuclear Cells
12%
Diagnostic Utility
12%
MicroRNA
12%
Multiple Variants
12%
Bladder Tumor
12%
Novel Biomarkers
12%
Small Biopsy
12%
Tumor Samples
12%
Heterogeneous Disease
12%
Cancer Immunity
12%
Exonic
12%
Intratumoral Heterogeneity
12%
Cystoscopy
12%
Clinical Staging
12%
Cancer mutations
12%
Cancer-related Inflammation
12%
Significantly mutated Genes
12%
Non-invasive Strategies
12%
Driver Genes
12%
Weighted Correlation Network Analysis (WGCNA)
12%
Serum Exosomes
12%
Tumor-derived Exosomes
12%
High Recurrence Rate
12%
5'UTR Variant
12%
Biochemistry, Genetics and Molecular Biology
Exome Sequencing
100%
Mutated Genes
100%
MicroRNA
100%
Peripheral Blood Mononuclear Cell
100%
KRAS
100%
Gene Network
100%